Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online April 27, 2007
Diabetes Care 30:1789-1794, 2007
DOI: 10.2337/dc06-2585
© 2007 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
dc06-2585v1
30/7/1789    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schindhelm, R. K.
Right arrow Articles by Teerlink, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schindhelm, R. K.
Right arrow Articles by Teerlink, T.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Pathophysiology/Complications
Original Article

Fasting and Postprandial Glycoxidative and Lipoxidative Stress Are Increased in Women With Type 2 Diabetes

Roger K. Schindhelm, BSC, MD1, Marjan Alssema, MSC2, Peter G. Scheffer, PHD3, Michaela Diamant, MD, PHD1, Jacqueline M. Dekker, PHD2, Rob Barto3, Giel Nijpels, MD, PHD2,4, Piet J. Kostense, PHD2,5, Robert J. Heine, MD, PHD1,2, Casper G. Schalkwijk, PHD6 and Tom Teerlink, PHD3

1 Department of Endocrinology, Vrije University (VU) Medical Center, Amsterdam, the Netherlands
2 Institute for Research in Extramural Medicine, VU Medical Center, Amsterdam, the Netherlands
3 Department of Clinical Chemistry, VU Medical Center, Amsterdam, the Netherlands
4 Department of General Practice, VU Medical Center, Amsterdam, the Netherlands
5 Department of Clinical Epidemiology and Biostatistics, VU Medical Center, Amsterdam, the Netherlands
6 Department of Internal Medicine, Academic Hospital Maastricht, Maastricht, the Netherlands

Address correspondence and reprint requests to T. Teerlink, PhD, VU University Medical Center, Clinical Chemistry, P.O. Box 7057, 1007 MB Amsterdam, Netherlands. E-mail: t.teerlink{at}vumc.nl

OBJECTIVE— We studied acute changes in markers of glycoxidative and lipoxidative stress, including oxidized LDL, N{varepsilon}-(carboxyethyl)-lysine (CEL), N{varepsilon}-(carboxymethyl)-lysine (CML), and 3-deoxyglucosone (3DG), following two consecutive meals.

RESEARCH DESIGN AND METHODS— Postmenopausal women (27 with normal glucose metabolism [NGM], 26 with type 2 diabetes) received two consecutive fat-rich meals and two consecutive carbohydrate-rich meals on two occasions. Glucose and triglyceride concentrations were measured at baseline and 1, 2, 4, 6, and 8 h following breakfast; lunch was given at 4 h. Oxidized LDL–to–LDL cholesterol ratio, CEL, CML, and 3DG were measured at baseline and at 8 h.

RESULTS— Fasting oxidized LDL–to–LDL cholesterol ratio, 3DG, and CML were higher in women with type 2 diabetes compared with women with NGM and were comparable to the postprandial values at 8 h in NGM. Postprandial rises in the oxidized LDL–to–LDL cholesterol ratio and 3DG were similar in both groups. However, the oxidized LDL–to–LDL cholesterol ratio increased more after the fat-rich meals, whereas CML and 3DG increased more after the carbohydrate-rich meals. After the fat-rich meals, the increase in the oxidized LDL–to–LDL cholesterol ratio correlated with postprandial triglycerides, whereas the increase in 3DG was correlated with postprandial glucose.

CONCLUSIONS— The acute changes in markers of glycoxidative and lipoxidative stress in both type 2 diabetes and NGM suggest that postabsorptive oxidative stress may partly underlie the association of postprandial derangements and cardiovascular risk.

Abbreviations: 3DG, 3-deoxyglucosone • AGE, advanced glycation end product • CAD, coronary artery disease • CEL, N{varepsilon}-(carboxyethyl)-lysine • CML, N{varepsilon}-(carboxymethyl)-lysine • CVD, cardiovascular disease • iAUC, incremental area under the curve • NGM, normal glucose metabolism


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2007 by the American Diabetes Association.